Clinical Trials on CD33 Expressing Hematological Malignancies
Total 1043 results
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHematologic Malignancy
-
St. Petersburg State Pavlov Medical UniversityCompletedHematologic MalignancyRussian Federation
-
Prolacta BioscienceActive, not recruiting
-
Exact Sciences CorporationTerminatedHematologic MalignancyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignancyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
Catholic University of the Sacred HeartPagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale PCompletedStem Cell Transplantation | Hematological MalignanciesItaly
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and Development; Fo...CompletedFebrile Neutropenia | Hematological MalignancyNetherlands
-
University Hospital, BrestCompletedFebrile Neutropenia | Hematological MalignancyFrance
-
Bellicum PharmaceuticalsWithdrawnMyelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphomas | Other High-risk Hematological Malignancies
-
University of RochesterRecruitingHematologic MalignanciesUnited States
-
Ascentage Pharma Group Inc.RecruitingHematologic MalignanciesUnited States, Australia
-
Julie-An M. TalanoMiltenyi Biotec, Inc.Active, not recruitingHematologic MalignanciesUnited States
-
Seoul National University HospitalMinistry of Health, Republic of Korea; The Korea Health Technology R&D Project...UnknownHematologic MalignanciesKorea, Republic of
-
Yale UniversityHospira, now a wholly owned subsidiary of PfizerCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignanciesUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedHematologic MalignanciesUnited States
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
Ruijin HospitalNot yet recruitingHematologic Malignancy
-
University Hospital TuebingenRecruitingHematologic MalignancyGermany
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingHematologic MalignancyItaly
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHematologic MalignancyChina
-
Duke UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingHematologic MalignancyUnited States
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Garcia, Jose M., MD, PhDActive, not recruitingHematologic MalignancyUnited States
-
Maisonneuve-Rosemont HospitalCanadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St.... and other collaboratorsCompletedHematologic MalignancyCanada
-
Massachusetts General HospitalCompleted
-
Alberta Health servicesUnknownHematologic MalignancyCanada
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedLymphoma | Leukemia | Myelodysplastic Syndrome | Hematological MalignanciesUnited States
-
Assiut UniversityUnknownFungal Infection
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society...RecruitingHematologic Malignancy | CaregiverUnited States
-
Brigham and Women's HospitalCompletedHematologic Malignancy | CaregiverUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedCancer | Septic Shock | AnemiaFrance
-
University of LiegeUniversity Hospital, Gasthuisberg; University Hospital, Ghent; University Hospital... and other collaboratorsActive, not recruitingHematological Malignancies | Graft-Versus-Host DiseaseBelgium
-
He HuangCompletedHematologic MalignanciesChina
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterChiron CorporationCompletedHematologic MalignanciesUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedHematologic MalignanciesUnited States
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); The Ottawa Hospital; Hamilton... and other collaboratorsCompletedHematologic MalignanciesCanada
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHematologic MalignanciesUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States